Crestwood Medical Center is seeking a certificate of need for the program after having performed the procedure more than 1,000 times as part of a research trial. The research, sponsored by Johns Hopkins Medical Institutes, revolves around whether hospitals without open-heart surgery can safely perform coronary angioplasty.
While a 2009 Mayo Clinic study found no difference in the safety or effectiveness of the procedure between hospitals with and without open-heart surgery, Huntsville Hospital CEO David Spillers is not convinced. He said the American College of Cardiology has warned against coronary angioplasty at hospitals that do not perform open-heart surgery, according to the report.
Related Articles on Hospital Cardiology:
AL’s Crestwood Medical Center Seeks Approval to Permanently Offer Angioplasty
Florida’s Doctors Hospital of Sarasota Cardiologists Oppose Plans for Stent Program
Tri-State Cardiology Joins Wellmont CVA Heart Institute in Tennessee
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
